Tumor irradiation followed by intratumoral cytokine gene therapy for murine renal adenocarcinoma

Cancer Gene Therapy

Volumn 11, Issue 1, 2004, Pages 61-72

  Hillman, Gilda G ^a   Slos, Philippe ^b   Wang, Yu ^a   Wright, Jennifer L ^a   Layer, Andrey ^a   De Meyer, Micael ^b   Yudelev, Mark ^a   Che, Mingxin ^a   Forman, Jeffrey D ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TRANSGENE S A   (France)

Author keywords

Adenovirus; IFN ; IL 2; Radiation; Renal carcinoma

Indexed keywords

ADENOVIRUS VECTOR; COMPLEMENTARY DNA; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DRUG EFFICACY; FEMALE; GENE INSERTION; HISTOPATHOLOGY; IMMUNE RESPONSE; INFLAMMATORY INFILTRATE; KIDNEY CARCINOMA; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR REGRESSION; VIRAL GENE THERAPY;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENETIC VECTORS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERFERON TYPE II; INTERLEUKIN-2; KIDNEY NEOPLASMS; MICE; NEOPLASM TRANSPLANTATION; SURVIVAL RATE; T-LYMPHOCYTES; TRANSGENES; UP-REGULATION;

ADENOVIRIDAE; ANIMALIA; INSERTION SEQUENCES; MURINAE;

EID: 0347986723     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700656     Document Type: Article

References (28)

1. Greenlee RT, Murray T, Bolden S, et al. Cancer statistics, 2000. CA Cancer J Clin. 2000;50:7-33.
2. Mulders P, Figlin R, deKernion JB, et al. Renal cell carcinoma: recent progress and future directions. Cancer Res. 1997;57:5189-5195.
3. Chow WH, Gridley G, McLaughlin JK, et al. Protein intake and risk of renal cell cancer. J Natl Cancer Inst. 1994;86:1131-1139.
4. Haas GP, Hillman GG. Update on the role of immunotherapy in the management of kidney cancer. Cancer Control. 1996;3:66-71.
5. Motzer RJ, Bander NH, Nanus DM. Renal-cell carcinoma. New England J Med. 1996;335:865-875.
6. Kim S, Haas GP, Hillman GG. Development of immunotherapy for the treatment of malignacies refractory to conventional therapies. Cytokines Mol Ther. 1996;2:13-19.
7. Hillman GG, Haas GP, Wahl WH, et al. Adoptive immunotherapy of cancer: biological response modifiers and cytotoxic cell therapy. Biotherapy. 1992;5:119-129.
8. Rosenberg SA, Lotze MT, Yang JC, et al. Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer. J Natl Cancer Inst. 1993;85:622-632.
9. Dybal EJ, Maughan RL, Sud S, et al. Synergy of radiation therapy and immunotherapy in murine renal cell carcinoma. J Urol. 1992;148:1331-1337.
10. Younes E, Haas GP, Dezso B, et al. Local tumor irradiation augments the response to IL-2 therapy in a murine renal adenocarcinoma. Cell Immunol. 1995; 165:243-251.
11. Dezso B, Haas GP, Hamzavi F, et al. The mechanism of local tumor irradiation combined with interleukin 2 therapy in murine renal carcinoma: histological evaluation of pulmonary metastases. Clin Cancer Res. 1996;2:1543-1552.
12. Hillman GG, Visscher D, Ali E, et al. Systemic treatment with interleukin-4 induces regression of pulmonary metastases in a murine renal cell carcinoma model. Cell Immunol. 1995;160:257-263.
13. Hillman GG, Visscher D, Hamzavi F, et al. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with IL-4. Clin Cancer Res. 1997;3:1799-1806.
14. Addison CL, Braciak T, Ralston R, et al. Intratumoral injection of an adenovirus expressing interleukin 2 induces regression and immunity in a murine breast cancer model. Proc Natl Acad Sci USA. 1995;92:8522-8526.
15. Addison CL, Bramson JL, Hitt MM, et al. Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumors. Gene Ther. 1998;5:1400-1409.
16. Cordier L, Duffour MT, Sabourin JC, et al. Complete recovery of mice from a pre-established tumor by direct intratumoral delivery of an adenovirus vector harboring the murine IL-2 gene. Gene Ther. 1995;2:16-21.
17. Huang H, Chen SH, Kosai K, et al. Gene therapy for hepatocellular carcinoma: long-term remission of primary and metastatic tumors in mice by interleukin-2 gene therapy in vitro. Gene Ther. 1996;3:980-987.
18. Toloza EM, Hunt K, Swisher S, et al. In vitro cancer gene therapy with a recombinant interleukin-2 adenovirus vector. Cancer Gene Ther. 1996;3:11-17.
19. Saffran DC, Horton HM, Yankauckas MA, et al. Immunotherapy of established tumors in mice by intratumoral injection of interleukin-2 plasmid DNA: induction of CD8+ T-cell immunity. Cancer Gene Ther. 1998;5:321-330.
20. Slos P, De Meyer M, Leroy P, et al. Immunotherapy of established tumors in mice by intratumoral injection of an adenovirus vector harboring the human IL-2 cDNA: induction of CD8(+) T-cell immunity and NK activity. Cancer Gene Ther. 2001;8:321-332.
21. Chartier C, Degryse E, Gantzer M, et al. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J Virol. 1996;70:4805-4810.
22. Chroboczek J, Bieber F, Jacrot B. The sequence of the genome of adenovirus type 5 and its comparison with the genome of adenovirus type 2. Virology. 1992;186:280-285.
23. Fallaux FJ, Bout A, van der Velde I, et al. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum Gene Ther. 1998;9:1909-1917.
24. Lusky M, Christ M, Rittner K, et al. In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2a, or E1/E4 deleted. J Virol. 1998;72:2022-2032.
25. Hillman GG, Maughan RL, Grignon DJ, et al. Neutron or photon irradiation for prostate tumors: enhancement of cytokine therapy in a metastatic tumor model. Clin Cancer Res. 2001;7:136-144.
26. Zeng M, Cerniglia GJ, Eck SL, et al. High-efficiency stable gene transfer of adenovirus into mammalian cells using ionizing radiation. Hum Gene Ther. 1997;8:1025-1032.
27. Hillman GG, Maughan RL, Grignon DJ, et al. Responsiveness of experimental prostate carcinoma bone tumors to neutron or photon radiation combined with cytokine therapy. Int J Rad Onc Biol Phys. 2003;56:1426-1437.
28. Bellone M, Iezzi G, Rovere P, et al. Processing of engulfed apoptotic bodies yields T cell epitopes. J Immunol. 1997;159:5391-5399.